Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BATM Advanced Communications Limited | BAV | May 31, 2024 | 0.18 | -5.88 |
Bio-Gate AG | BIG1 | May 31, 2024 | 0.97 | +2.11 |
Carl Zeiss Meditec A G | AFXA | May 31, 2024 | 85.50 | -4.47 |
Carmat | CXT | May 31, 2024 | 3.08 | -1.28 |
Cochlear Ltd. | OC5 | May 31, 2024 | 198.18 | +1.44 |
Cochlear Ltd. | OC50 | May 31, 2024 | 95.50 | +1.06 |
COLOPLAST AS ADR | CBH | May 31, 2024 | 11.00 | +1.85 |
ConvaTec Group plc American Depositary Receipts - Unsponsore | 2CVU | May 31, 2024 | 11.50 | 0.00 |
Creo Medical Group plc | 1RC | May 31, 2024 | 0.42 | +2.97 |
Crossject | 74C | May 31, 2024 | 2.46 | +17.14 |
Cyberdyne Inc | 8C4 | May 31, 2024 | 1.10 | -0.18 |
DMS | DMS1 | May 31, 2024 | 0.91 | +0.67 |
Elexxion AG | E8X | May 31, 2024 | 0.09 | +50.00 |
EssilorLuxottica American Depositary Receipts - Unsponsored | ESLC | May 31, 2024 | 101.00 | 0.00 |
Euromedis Groupe | 61R | May 31, 2024 | 4.44 | 0.00 |
Fisher & Paykel Healthcare Corporation Limited | FPLB | May 31, 2024 | 16.30 | +3.82 |
Genomtec S.A. | 4VI | May 31, 2024 | 2.42 | -1.62 |
HeraMED Limited | 1I4 | May 31, 2024 | 0.01 | 0.00 |
Hoya Corporation | HYB | May 31, 2024 | 112.65 | +2.88 |
Implanet | IM11 | May 31, 2024 | 0.09 | -2.08 |
Inspecs Group Plc | 4GV | May 31, 2024 | 0.77 | -2.55 |
Inspiration Healthcare Group Plc | LXD1 | May 31, 2024 | 0.19 | +2.14 |
Japan Medical Dynamic Marketing Inc. | JMD | May 31, 2024 | 3.58 | +1.70 |
JINS Holdings Inc. | 5F3 | May 31, 2024 | 21.20 | 0.00 |
Kangji Medical Holdings Limited | 50J | May 31, 2024 | 0.69 | -0.71 |
Kromek Group Plc | 4KM | May 31, 2024 | 0.08 | -3.53 |
Menicon Co.Ltd | 5FR | May 31, 2024 | 7.40 | +2.07 |
Mercator Medical S. A | MM2 | May 31, 2024 | 10.34 | -0.39 |
MICROPORT | MSK | May 31, 2024 | 0.69 | 0.00 |
Microport Cardioflow Medtech Corporation | 72X | May 31, 2024 | 0.11 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.